Prostate Cancer - Results from #25240

Diffusion-weighted imaging of local recurrent prostate cancer after radiation therapy: Comparison with 22-core three-dimensional prostate mapping biopsy - Abstract August 24, 2012

Association between family history of prostate cancer and positive biopsies in a Brazilian screening program - Abstract August 24, 2012

Influence of high-definition multileaf collimator for three-dimensional conformal radiotherapy and intensity-modulated radiotherapy of prostate cancer - Abstract August 24, 2012

External validation of the updated briganti nomogram to predict lymph node invasion in prostate cancer patients undergoing extended lymph node dissection - Abstract August 24, 2012

Unusually large numbers needed to treat for radical prostatectomy in prostate cancer patients with PSA velocity ≤ 2 ng/ml/year - Abstract August 24, 2012

Impact of total PSA, PSA doubling time and PSA velocity on detection rates of (11)C-Choline positron emission tomography in recurrent prostate cancer - Abstract August 24, 2012

Docetaxel: A review of its use for the first-line treatment of advanced castration-resistant prostate cancer - Abstract August 24, 2012

Prostate biopsy in response to a change in nadir prostate specific antigen of 0.4 ng/ml after treatment with 5α-reductase inhibitors markedly enhances the detection rate of prostate cancer - Abstract August 23, 2012

Preoperative statin therapy is not associated with biochemical recurrence after radical prostatectomy: Our experience and meta-analysis - Abstract August 23, 2012

Sex hormone-binding globulin is an independent predictor of biochemical recurrence after radical prostatectomy - Abstract August 23, 2012

Assessment of the quality of medical care among patients with early stage prostate cancer undergoing expectant management in the United States - Abstract August 23, 2012

Identifying candidates for active surveillance: An evaluation of the repeat biopsy strategy for men with favorable risk prostate cancer - Abstract August 23, 2012

Localised prostate cancer: The PREFERE trial - Abstract August 23, 2012

Prostate-specific antigen spikes with (131)Cs brachytherapy. Is there a difference with other radioisotopes? - Abstract August 23, 2012

Is there an advantage in designing adapted, patient-specific PTV margins in intensity modulated proton beam therapy for prostate cancer? - Abstract August 23, 2012

The accuracy of different biopsy strategies for the detection of clinically important prostate cancer: A computer simulation - Abstract August 23, 2012

Comparison of different mathematical models of diffusion-weighted prostate MR imaging - Abstract August 23, 2012

Is the impact of the extent of lymphadenectomy in radical prostatectomy related to the disease risk? A single center prospective study - Abstract August 23, 2012

Validation of the European Society of Urogenital Radiology scoring system for prostate cancer diagnosis on multiparametric magnetic resonance imaging in a cohort of repeat biopsy patients - Abstract August 23, 2012

It takes two to talk about prostate cancer: A qualitative assessment of African American men's and women's cancer communication practices and recommendations - Abstract August 22, 2012

Page 1263 of 1447